Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Pritsana Raungrut

5PUBLICATIONS

8CO-AUTHORS

Molecular targetsPredictive and prognostic markersMedical virology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Nov 27, 2025

Tiliacorinine as a Promising Candidate for Cholangiocarcinoma Therapy via Oxidative Stress Molecule Modulation: A Study Integrating Network Pharmacology, Molecular Docking and Molecular Dynamics Simulation.

Tavisa Boonsit, Moragot Chatatikun, Suphasarang Sirirattanakul

|Jul 29, 2025

Proteomic Profiling Reveals TPR and FGA as Predictive Serum Biomarkers of Relapse to First- and Second-Generation EGFR-TKIs in Advanced Lung Adenocarcinoma.

Pritsana Raungrut, Wararat Chiangjong, Thipphanet Masjon

|Dec 27, 2024

Transcriptomic Profiling of Carboplatin- and Paclitaxel-Resistant Lung Adenocarcinoma Cells Reveals <i>CSF3</i> as a Potential Biomarker for the Carboplatin Plus Paclitaxel Doublet Regimens.

Pritsana Raungrut, Suchanan Tanyapattrapong, Thipphanet Masjon

|Oct 30, 2020

Serum miRNAs associated with tumor-promoting cytokines in non-small cell lung cancer.

Pichitpon Chaniad, Keson Trakunran, Sarayut Lucien Geater

|Sep 18, 2020

Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer.

Keson Trakunram, Pichitpon Chaniad, Sarayut Lucien Geater

Pageof 1

Frequent Collaborators

1 joint publications

Paramee Thongsuksai

1 joint publications

Wararat Chiangjong

1 joint publications

Narongwit Nakwan

1 joint publications

Moragot Chatatikun

1 joint publications

Suphasarang Sirirattanakul

1 joint publications

Imran Sama-Ae

1 joint publications

Fumitaka Kawakami

1 joint publications

Atthaphong Phongphithakchai

Frequent Collaborators

1 joint publications

Paramee Thongsuksai

1 joint publications

Wararat Chiangjong

1 joint publications

Narongwit Nakwan

1 joint publications

Moragot Chatatikun

Top Related Videos

Network Pharmacology Prediction and Experimental Validation of <em>Trichosanthes</em>-<em>Fritillaria thunbergii</em> Action Mechanism Against Lung Adenocarcinoma

Network Pharmacology Prediction and Experimental Validation of <em>Trichosanthes</em>-<em>Fritillaria thunbergii</em> Action Mechanism Against Lung Adenocarcinoma

Published on : Mar 03, 2023

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

Construction of An Orthotopic Xenograft Model of Non-Small Cell Lung Cancer Mimicking Disease Progression and Predicting Drug Activities

Construction of An Orthotopic Xenograft Model of Non-Small Cell Lung Cancer Mimicking Disease Progression and Predicting Drug Activities

Published on : May 10, 2024

See more related videos

Top Related Videos

Network Pharmacology Prediction and Experimental Validation of <em>Trichosanthes</em>-<em>Fritillaria thunbergii</em> Action Mechanism Against Lung Adenocarcinoma

Network Pharmacology Prediction and Experimental Validation of <em>Trichosanthes</em>-<em>Fritillaria thunbergii</em> Action Mechanism Against Lung Adenocarcinoma

Published on : Mar 03, 2023

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

Construction of An Orthotopic Xenograft Model of Non-Small Cell Lung Cancer Mimicking Disease Progression and Predicting Drug Activities

Construction of An Orthotopic Xenograft Model of Non-Small Cell Lung Cancer Mimicking Disease Progression and Predicting Drug Activities

Published on : May 10, 2024

See more related videos